Alcidion Group Limited (ASX:ALC)
Australia · Delayed Price · Currency is AUD | Market Cap | 134.36M +9.9% |
| Revenue (ttm) | 51.64M +26.6% |
| Net Income | 2.29M +38.2% |
| EPS | 0.00 +41.8% |
| Shares Out | 1.34B |
| PE Ratio | 58.82 |
| Forward PE | 47.62 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 89,073 |
| Open | 0.1000 |
| Previous Close | 0.1000 |
| Day's Range | 0.1000 - 0.1000 |
| 52-Week Range | 0.0820 - 0.1450 |
| Beta | 1.08 |
| Analysts | Buy |
| Price Target | 0.15 (+50.0%) |
| Earnings Date | Oct 28, 2026 |
About Alcidion Group
Alcidion Group Limited, together with its subsidiaries, develops and sells digital health software solutions for healthcare organisations in Australia, New Zealand, and the United Kingdom. It offers Miya Precision, a fast healthcare interoperability resource (FHIR) events platform that integrates digital patient care services, such as a clinical decision support system, electronic patient record (EPR), and patient administration systems (PAS). The company's platform also provides electronic patient flow journey boards; virtual care and remote p... [Read more]
Financial Performance
In fiscal year 2026, Alcidion Group's revenue was 51.64 million, an increase of 26.61% compared to the previous year's 40.79 million. Earnings were 2.29 million, an increase of 38.15%.
Financial StatementsAnalyst Summary
According to 4 analysts, the average rating for ALC stock is "Buy." The 12-month stock price target is $0.15, which is an increase of 50.00% from the latest price.
News
Alcidion Group Earnings Call Transcript: H2 2026
Record FY 2026 results with 27% revenue growth, 34% higher ARR, and strong cash position. Strategic Kyra acquisition expanded market leadership and customer base. FY 2027 outlook is positive, with robust contracted revenue and continued growth expected.
Alcidion Group Annual report: H2 2026
Alcidion Group has published its H2 2026 annual report on August 18, 2026.
Alcidion Group Slides: H2 2026
Alcidion Group has posted slides in relation to its H2 2026 quarterly earnings report, which was published on August 18, 2026.
Alcidion Group Earnings release: H2 2026
Alcidion Group released its H2 2026 earnings on August 18, 2026, summarizing the period's financial results.
Q4 2026 Alcidion Group Ltd Activities Report Call Transcript
Q4 2026 Alcidion Group Ltd Activities Report Call Transcript
Alcidion Group Earnings Call Transcript: Q4 2026
Record operating cash flow and revenue growth were achieved, driven by major contract wins and the strategic Kyra acquisition. Strong recurring revenue, robust cash position, and expanding market presence underpin positive guidance for FY 2026 and momentum into FY 2027.
Alcidion Group Earnings release: Q4 2026
Alcidion Group released its Q4 2026 earnings on July 22, 2026, summarizing the period's financial results.
Alcidion Signs Contract With University Hospitals Sussex For Miya Precision EPR Platform
(RTTNews) - Alcidion Group (ALC.AX) has signed a contract with University Hospitals Sussex for Miya Precision EPR platform. The platform will give clinicians real time access to patient records whilst...
Alcidion Group Earnings Call Transcript: Q3 2026
Q3 FY2026 saw strong new sales, contract expansions, and strategic wins in the U.K. and Australia, driving recurring revenue and positive cash flow. Revenue is expected to exceed AUD 50 million for the year, with significant growth anticipated in Q4 and continued geographic expansion.
Alcidion Group Earnings release: Q3 2026
Alcidion Group released its Q3 2026 earnings on April 28, 2026, summarizing the period's financial results.
Alcidion Group Earnings Call Transcript: H1 2026
Record H1 revenue and EBITDA growth were driven by recurring revenue and major contract wins, especially in the UK. Guidance for FY 2026 anticipates revenue above AUD 50 million, with continued expansion into new markets and a strong sales pipeline.
Alcidion Group Quarterly report: H1 2026
Alcidion Group has published its H1 2026 quarterly earnings report on February 25, 2026.
Alcidion Group Slides: H1 2026
Alcidion Group has posted slides in relation to its H1 2026 quarterly earnings report, which was published on February 25, 2026.
Alcidion Group Earnings release: H1 2026
Alcidion Group released its H1 2026 earnings on February 25, 2026, summarizing the period's financial results.
Alcidion Group Earnings Call Transcript: Q2 2026
Q2 FY 2026 saw strong contract wins, including a major Leidos expansion and selection as preferred provider for UHS Sussex, driving a 40% year-over-year increase in contracted revenue. Cash position remains robust, with positive outlook for FY 2026 pending further contract finalizations.
Alcidion Group Earnings release: Q2 2026
Alcidion Group released its Q2 2026 earnings on January 14, 2026, summarizing the period's financial results.
Alcidion Group Earnings Call Transcript: Q1 2026
Strongest Q1 in two years with AUD 8.2M in new sales and improved cash flow. Major contract expansions and successful deployments in the UK and Australia underpin positive FY 2026 guidance, with continued focus on international growth and digital innovation.
Alcidion Group Earnings release: Q1 2026
Alcidion Group released its Q1 2026 earnings on October 27, 2025, summarizing the period's financial results.
Alcidion Group Transcript: AGM 2025
Record FY2025 results included strong revenue growth, improved EBITDA, and a robust cash position. Strategic focus remains on expanding the Miya Precision platform, entering new markets, and leveraging AI, while addressing healthcare workforce and digital transformation challenges.
Alcidion Group Slides: FY 2025
Alcidion Group has posted slides in relation to its FY 2025 quarterly earnings report, which was published on October 16, 2025.
Alcidion Group Slides: Investor Presentation
Alcidion Group has posted slides in relation to its latest quarterly earnings report, which was published on September 14, 2025.